Early Neolithic Landscape and Society in Southwest Scania – New Results and Perspectives

The last two decades of excavations in southwest Scania, Sweden, have given substantial new results regarding Early Neolithic society (4000–3300 cal. BC). The overall aim here is to discuss and synthesize these results, and a number of important excavations are also presented in detail. The results are both on a macro scale concerning overall settlement pattern, landscape use and the scale of monumental landscapes, and on a micro scale concerning, for example, houses and huts, monumental sites and their complexity, and pits and depositional practices on different types of sites. Also, the economy of the region as well as the socio-political organization are discussed based on interpretations of the material presented

The Funnel Beaker Culture in action. Early and Middle Neolithic monumentality in Southwestern Scania, Sweden (4000-3000 cal BC)

One of the most discussed issues in European archaeology is the significance and context of monumentality and the construction of long barrows and megaliths in the Neolithic. The construction of monuments in Neolithic Europe can, due to their often significant size and complexity, be interpreted as signs of collective building efforts, but the social and political background may vary from more egalitarian to highly stratified societies. During the last 20 years of surveys and archaeological excavations in southwest Scania, Sweden, new archaeological results have been produced, revealing many hitherto unknown settlements, central places for feasting, long barrows, megaliths, free-standing façades and other types of monumental constructions. This has disclosed a much more complex picture of the Early Neolithic (4000–3300 cal BC) Funnel Beaker Culture societies in the region. Large-scale excavations have documented a hierarchy of monumental places in Early Neolithic southern Scandinavia, probably reflecting different uses of monuments, mirroring a social hierarchy in polities. Recently, another central place has been excavated at Flackarp, south of Lund, Sweden, containing at least nine dolmens and free-standing façades, further supporting this hypothesis

No effect of remdesivir or betamethasone on upper respiratory tract SARS-CoV-2 RNA kinetics in hospitalised COVID-19 patients: a retrospective observational study

Background The viral kinetics of SARS-CoV-2 has been considered clinically important. While remdesivir and corticosteroids are recommended for COVID-19 patients requiring oxygen support, there is a limited number of published reports on viral kinetics in hospitalised patients with COVID-19 treated with remdesivir or corticosteroids. Methods We conducted a retrospective study by collecting longitudinal samples from the nasopharynx/throat of 123 hospitalised patients (median age 55 years, 74% male) with COVID-19, to evaluate the effects of remdesivir and corticosteroid treatment on viral RNA levels. The subjects were divided into four groups: those receiving remdesivir (n = 25), betamethasone (n = 41), both (n = 15), or neither (n = 42). Time to viral RNA clearance was analysed using Kaplan-Meier plots, categorical data were analysed using Fisher\u27s exact test, and Kruskal-Wallis for continuous data. Viral RNA decline rate was analysed using a mixed effect model. Results We found no significant difference in SARS-CoV-2 RNA decline rate or time to SARS-CoV-2 RNA clearance between the groups. Moreover, clinical status at baseline was not correlated with time to viral clearance. Conclusions Since SARS-CoV-2 RNA kinetics was not affected by treatment, repeated sampling from the upper respiratory tract cannot be used to evaluate treatment response

11,000 h of chemical-looping combustion operation—Where are we and where do we want to go?

A key for chemical-looping combustion (CLC) is the oxygen carrier. The ultimate test is obviously the actual operation, which reveals if it turns to dust, agglomerates or loses its reactivity or oxygen carrier capacity. The CLC process has been operated in 46 smaller chemical-looping combustors, for a total of more than 11,000 h. The operation involves both manufactured oxygen carriers, with 70% of the total time of operation, and less costly materials, i.e. natural ores or waste materials. Among manufactured materials, the most popular materials are based on NiO with 29% of the operational time, Fe2O3 with 16% and CuO with 13%. Among the monometallic oxides there are also Mn3O4 with 1%, and CoO with 2%. The manufactured materials also include a number of combined oxides with 11% of operation, mostly calcium manganites and other combined manganese oxides. Finally, the natural ores and waste materials include ilmenite, FeTiO3 with 13%, iron ore/waste with 9% and manganese ore with 6%. In the last years a shift towards more focus on CuO, combined oxides and natural ores has been seen. The operational experience shows a large variation in performance depending on pilot design, operational conditions, solids inventory, oxygen carrier and fuel. However, there is at present no experience of the process at commercial or semi-commercial scale, although oxygen-carrier materials have been successfully used in commercial fluidized-bed boilers for Oxygen-Carrier Aided Combustion (OCAC) during more than 12,000 h of operation. The paper discusses strategies for upscaling as well as the use of biomass for negative emissions. A key question is how scaling-up will affect the performance, which again will determine the costs for purification of CO2 through e.g. oxy-polishing. Unfortunately, the conditions in the small-scale pilots do not allow for any safe conclusions with respect to performance in full scale. Nevertheless, the experiences from pilot operation shows that the process works and can be expected to work in the large scale and gives important information, for instance on the usefulness of various oxygen-carriers. Because further research is not likely to improve our understanding of the performance that can be achieved in full scale, there is little sense in waiting with the scale-up. A major difficulty with the scaling-up of a novel process is in the risk. First-of-its-kind large-scale projects include risks of technical mistakes and unforeseen obstacles, leading to added costs or, in the worst case, failure. One way of addressing these risks is to focus on the heart of the process and build it with maximum flexibility for future use. A concept for maximum flexibility is the Multipurpose Dual Fluidized Bed (MDFB). Another is to find a suitable existing plant, e.g. a dual fluidized-bed thermal gasifier. With present emissions the global CO2 budget associated with a maximum temperature of 2 \ub0C may be spent in around 20–25 years, whereas the CO2 budget for 1.5 \ub0C is may be exhausted in 10 years. Thus, the need for both CO2 neutral fuels and negative emissions will become increasingly urgent as we are nearing or transgressing the maximum amount of CO2 that can be emitted without compromising the global climate agreement in Paris saying we must keep “well below” 2 \ub0C and aim for a maximum of 1.5 \ub0C. Thus, biomass may turn out to be a key fuel for Carbon Capture and Storage (CCS), because CO2-free power does not necessarily need CCS, but negative emissions will definitely need Bio-CCS

Non-inhibitory levels of oxygen during cultivation increase freeze-drying stress tolerance in Limosilactobacillus reuteri DSM 17938

The physiological effects of oxygen on Limosilactobacillus reuteri DSM 17938 during cultivation and the ensuing properties of the freeze-dried probiotic product was investigated. On-line flow cytometry and k-means clustering gating was used to follow growth and viability in real time during cultivation. The bacterium tolerated aeration at 500mL/min, with a growth rate of 0.74 +/- 0.13h(-1) which demonstrated that low levels of oxygen did not influence the growth kinetics of the bacterium. Modulation of the redox metabolism was, however, seen already at non-inhibitory oxygen levels by 1.5-fold higher production of acetate and 1.5-fold lower ethanol production. A significantly higher survival rate in the freeze-dried product was observed for cells cultivated in presence of oxygen compared to absence of oxygen (61.8%+/- 2.4% vs. 11.5%+/- 4.3%), coinciding with a higher degree of unsaturated fatty acids (UFA:SFA ratio of 10 for air sparged vs. 3.59 for N-2 sparged conditions.). Oxygen also resulted in improved bile tolerance and boosted 5 ' nucleotidase activity (370U/L vs. 240U/L in N-2 sparged conditions) but lower tolerance to acidic conditions compared bacteria grown under complete anaerobic conditions which survived up to 90min of exposure at pH 2. Overall, our results indicate the controlled supply of oxygen during production may be used as means for probiotic activity optimization of L. reuteri DSM 17938

Non-inhibitory levels of oxygen during cultivation increase freeze-drying stress tolerance in Limosilactobacillus reuteri DSM 17938

The physiological effects of oxygen on Limosilactobacillus reuteri DSM 17938 during cultivation and the ensuing properties of the freeze-dried probiotic product was investigated. On-line flow cytometry and k-means clustering gating was used to follow growth and viability in real time during cultivation. The bacterium tolerated aeration at 500 ml/min, with a growth rate of 0.74 ± 0.13 h-1 which demonstrated that low levels of oxygen did not influence the growth kinetics of the bacterium. Modulation of the redox metabolism was, however, seen already at non-inhibitory oxygen levels by 1.5-fold higher production of acetate and 1.5-fold lower ethanol production. A significantly higher survival rate in the freeze-dried product was observed for cells cultivated in presence of oxygen compared to absence of oxygen (61.8 ± 2.4 % vs 11.5 ± 4.3 %), coinciding with a higher degree of unsaturated fatty acids (UFA:SFA ratio of 10 for air sparged vs 3.59 for N2 sparged conditions.). Oxygen also resulted in improved bile tolerance and boosted 5’nucleotidase activity (370 U/L vs 240 U/L in N2 sparged conditions) but lower tolerance to acidic conditions compared bacteria grown under complete anaerobic conditions which survived up to 90 min of exposure at pH 2. Overall, our results indicate the controlled supply of oxygen during production may be used as means for probiotic activity optimisation of L. reuteri DSM 17938

Leukotriene receptors (version 2020.3) in the IUPHAR/BPS Guide to Pharmacology Database

The leukotriene receptors (nomenclature as agreed by the NC-IUPHAR subcommittee on Leukotriene Receptors [34, 37]) are activated by the endogenous ligands leukotrienes (LT), synthesized from lipoxygenase metabolism of arachidonic acid. The human BLT1 receptor is the high affinity LTB4 receptor whereas the BLT2 receptor in addition to being a low-affinity LTB4 receptor also binds several other lipoxygenase-products, such as 12S-HETE, 12S-HPETE, 15S-HETE, and the thromboxane synthase product 12-hydroxyheptadecatrienoic acid. The BLT receptors mediate chemotaxis and immunomodulation in several leukocyte populations and are in addition expressed on non-myeloid cells, such as vascular smooth muscle and endothelial cells. In addition to BLT receptors, LTB4 has been reported to bind to the peroxisome proliferator activated receptor (PPAR) α [196] and the vanilloid TRPV1 ligand-gated nonselective cation channel [217]. The receptors for the cysteinyl-leukotrienes (i.e. LTC4, LTD4 and LTE4) are termed CysLT1 and CysLT2 and exhibit distinct expression patterns in human tissues, mediating for example smooth muscle cell contraction, regulation of vascular permeability, and leukocyte activation. There is also evidence in the literature for additional CysLT receptor subtypes, derived from functional in vitro studies, radioligand binding and in mice lacking both CysLT1 and CysLT2 receptors [37]. Cysteinyl-leukotrienes have also been suggested to signal through the P2Y12 receptor [96, 243, 272], GPR17 [57] and GPR99 [168]

Leukotriene receptors in GtoPdb v.2023.1

The leukotriene receptors (nomenclature as agreed by the NC-IUPHAR subcommittee on Leukotriene Receptors [35, 38]) are activated by the endogenous ligands leukotrienes (LT), synthesized from lipoxygenase metabolism of arachidonic acid. The human BLT1 receptor is the high affinity LTB4 receptor whereas the BLT2 receptor in addition to being a low-affinity LTB4 receptor also binds several other lipoxygenase-products, such as 12S-HETE, 12S-HPETE, 15S-HETE, and the thromboxane synthase product 12-hydroxyheptadecatrienoic acid. The BLT receptors mediate chemotaxis and immunomodulation in several leukocyte populations and are in addition expressed on non-myeloid cells, such as vascular smooth muscle and endothelial cells. In addition to BLT receptors, LTB4 has been reported to bind to the peroxisome proliferator activated receptor (PPAR) α [201] and the vanilloid TRPV1 ligand-gated nonselective cation channel [223]. The crystal structure of the BLT1 receptor was initially determined in complex with selective antagonists [141, 231] and has recently been extended to the cryo-electron microscopy structure of LTB4-bound human BLT1 receptor at 2.91 Å resolution [389]. The receptors for the cysteinyl-leukotrienes (i.e. LTC4, LTD4 and LTE4) are termed CysLT1 and CysLT2 and exhibit distinct expression patterns in human tissues, mediating for example smooth muscle cell contraction, regulation of vascular permeability, and leukocyte activation. Quite recently, the the crystal structures of both receptors have been solved, the CysLT1 in complex with zafirlukast and pranlukast [203] and the CysLT2 in complex with three dual CysLT1/CysLT2 antagonists [122]. There is also evidence in the literature for additional CysLT receptor subtypes, derived from functional in vitro studies, radioligand binding and in mice lacking both CysLT1 and CysLT2 receptors [38]. Cysteinyl-leukotrienes have also been suggested to signal through the P2Y12 receptor [99, 251, 280], GPR17 [60] and GPR99 [173]

A baseline study of the occurrence of non-indigenous species in Danish harbours

Project Manager/Main Author Jesper H. AndersenWe report the first ever nation-wide study of the occurrence of non-indigenous species in Danish harbours. The sampling was car-ried out using both conventional and biomolecular methods (eDNA). In total, 16 harbours were covered – Esbjerg and Aarhus, the two largest harbours in Denmark, with intensive sampling and 14 harbours with a reduced programme. 26 non-indigenous species were recorded using conventional sampling and 13 species were recorded using eDNA-based methods. Excluding overlapping rec-ords, we have recorded a total of 34 non-indigenous species in the 16 harbours studied. Based on the results, we conclude the following: 1) more non-indigenous species are found in the western parts of Denmark (North Sea region) then in the eastern parts (Baltic Sea), and 2) a few species previously unseen in Danish marine waters were recorded, i.e. the two bristle worms Eteone het-eropoda (fam. Phyllodocidae) and Streblospio benedicti (fam. Spionidae). Further, we provide a proof-of-concept regarding the overarching objectives of the MONIS 1-3 projects and the eDNA-based test systems developed. The results constitute a baseline for future studies in Danish ports and other hotspot areas.publishedVersio

Leukotriene receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

The leukotriene receptors (nomenclature as agreed by the NC-IUPHAR subcommittee on Leukotriene Receptors [31, 34]) are activated by the endogenous ligands leukotrienes (LT), synthesized from lipoxygenase metabolism of arachidonic acid. The human BLT1 receptor is the high affinity LTB4 receptor whereas the BLT2 receptor in addition to being a low-affinity LTB4 receptor also binds several other lipoxygenase-products, such as 12S-HETE, 12S-HPETE, 15S-HETE, and the thromboxane synthase product 12-hydroxyheptadecatrienoic acid. The BLT receptors mediate chemotaxis and immunomodulation in several leukocyte populations and are in addition expressed on non-myeloid cells, such as vascular smooth muscle and endothelial cells. In addition to BLT receptors, LTB4 has been reported to bind to the peroxisome proliferator activated receptor (PPAR) α [189] and the vanilloid TRPV1 ligand-gated nonselective cation channel [210]. The receptors for the cysteinyl-leukotrienes (i.e. LTC4, LTD4 and LTE4) are termed CysLT1 and CysLT2 and exhibit distinct expression patterns in human tissues, mediating for example smooth muscle cell contraction, regulation of vascular permeability, and leukocyte activation. There is also evidence in the literature for additional CysLT receptor subtypes, derived from functional in vitro studies, radioligand binding and in mice lacking both CysLT1 and CysLT2 receptors [34]. Cysteinyl-leukotrienes have also been suggested to signal through the P2Y12 receptor [91, 236, 265], GPR17 [53] and GPR99 [161]